Pulmonary Vasculature

Latest News

COVID19 Vaccine Is Safe Despite Reports of Deadly Clots

The AstraZeneca vaccine, developed with researchers from Oxford University, has been heavily used in Britain

Examining Changes in PASP After Atrial Defect Closure in Older Patients With Systolic, Diastolic, and Renal Dysfunction

Patients who are older and have systolic, diastolic, and renal dysfunction may benefit from peri-interventional preload reduction therapy before implantation of larger left atrial devices.

Exercise Doppler Echocardiography Found to Consistently Assess Right Heart, Pulmonary Circulation

Exercise Doppler echocardiography may provide consistent assessment of right heart function and pulmonary circulation when conducted at expert centers.

High Hepatic Growth Factor Levels Add Predictive Value to PAH Risk Score

In pulmonary arterial hypertension, high plasma levels of hepatic growth factor are associated with the right heart maladaptive phenotype and are incremental to the REVEAL score for the prediction of patient outcomes.

Inhaled Treprostinil Beneficial in Pulmonary Hypertension

Exercise capacity improved, clinical worsening reduced for patients with pulmonary HTN due to interstitial lung disease.

Short-Term Clinical Outcomes After Transcatheter Pulmonary Valve Replacement Using a Sapien Valve

Patients undergoing transcatheter pulmonary valve replacement using a Sapien valve had satisfactory short-term clinical outcomes.

Implantable Infusion Pump for Treprostinil in Pulmonary Arterial Hypertension Is Safe, Feasible

Patients with pulmonary arterial hypertension (PAH) who were treated with treprostinil using an implantable infusion pump experienced few serious complications.

Heparin, von Willebrand Factor Interaction to Predict Bleeding During Cardiopulmonary Bypass

Predicting bleeding during cardiopulmonary bypass is complex and not captured by tests, including measuring von Willebrand factor interaction.

Noninvasive Combinatorial Model Predicts Pulmonary Hypertension

A combinatorial model was devised to predict pulmonary hypertension using systolic pulmonary artery pressure and forced vital capacity in older adults.

Pulmonary Artery Denervation for the Treatment of PAH

Pulmonary artery denervation has been found to reduce the sympathetic activity of the pulmonary circulation.